Ampio Pharmaceuticals, Inc. (AMPE)

USD 0.0

(0.0%)

Gross Profit Summary of Ampio Pharmaceuticals, Inc.

  • Ampio Pharmaceuticals, Inc.'s latest annual gross profit in 2023 was -250 Thousand USD , up 87.97% from previous year.
  • Ampio Pharmaceuticals, Inc.'s latest quarterly gross profit in 2023 FY was -250 Thousand USD , up 87.97% from previous quarter.
  • Ampio Pharmaceuticals, Inc. reported a annual gross profit of -2.07 Million USD in annual gross profit 2022, down -90.04% from previous year.
  • Ampio Pharmaceuticals, Inc. reported a annual gross profit of -1.09 Million USD in annual gross profit 2021, up 7.13% from previous year.
  • Ampio Pharmaceuticals, Inc. reported a quarterly gross profit of - USD for 2023 Q2, up 100.0% from previous quarter.
  • Ampio Pharmaceuticals, Inc. reported a quarterly gross profit of -245 Thousand USD for 2023 Q1, up 33.6% from previous quarter.

Annual Gross Profit Chart of Ampio Pharmaceuticals, Inc. (2023 - 2006)

Historical Annual Gross Profit of Ampio Pharmaceuticals, Inc. (2023 - 2006)

Year Gross Profit Gross Profit Growth
2023 -250 Thousand USD 87.97%
2022 -2.07 Million USD -90.04%
2021 -1.09 Million USD 7.13%
2020 -1.17 Million USD 7.39%
2019 -1.27 Million USD -143.21%
2018 -523 Thousand USD 7.92%
2017 -568 Thousand USD 40.21%
2016 -950 Thousand USD -219.78%
2015 793.15 Thousand USD 136.65%
2014 -2.16 Million USD -28.21%
2013 -1.68 Million USD -20.66%
2012 -1.39 Million USD -7561.33%
2011 18.75 Thousand USD 0.0%
2010 - USD 0.0%
2009 - USD 100.0%
2008 -950.00 USD 0.0%
2007 - USD 0.0%
2006 - USD 0.0%

Peer Gross Profit Comparison of Ampio Pharmaceuticals, Inc.

Name Gross Profit Gross Profit Difference
AIM ImmunoTech Inc. 160 Thousand USD 256.25%
Armata Pharmaceuticals, Inc. -29.24 Million USD 99.145%
Actinium Pharmaceuticals, Inc. -709 Thousand USD 64.739%
Azitra, Inc. 260.45 Thousand USD 195.987%
Can-Fite BioPharma Ltd. 743 Thousand USD 133.647%
Chromocell Therapeutics Corporation -2.57 Million USD 90.308%
Calidi Biotherapeutics, Inc. -1.25 Million USD 80.096%
CEL-SCI Corporation -3.95 Million USD 93.684%
iBio, Inc. -1.02 Million USD 75.61%
Lineage Cell Therapeutics, Inc. 8.27 Million USD 103.022%
MAIA Biotechnology, Inc. - USD Infinity%
Matinas BioPharma Holdings, Inc. -13.39 Million USD 98.133%
Navidea Biopharmaceuticals, Inc. -119.29 Thousand USD -109.565%
NovaBay Pharmaceuticals, Inc. 7.89 Million USD 103.167%
NanoViricides, Inc. -759.01 Thousand USD 67.063%
Oragenics, Inc. -15.45 Million USD 98.382%
BiomX Inc. -1.22 Million USD 79.642%
BiomX Inc. -1.22 Million USD 79.642%
Protalix BioTherapeutics, Inc. 42.51 Million USD 100.588%
Palatin Technologies, Inc. 4.39 Million USD 105.692%
Scorpius Holdings, Inc. -2.21 Million USD 88.721%